About
About Dongwha Pharm.Co.,Ltd
Dongwha Pharm.Co.,Ltd manufactures and sells pharmaceutical products in South Korea. It offers ethical products in the areas of alimentary system, antibiotic, cardiovascular/metabolic disease, NSAID/respiratory system, muscle relaxants/musculoskeletal system, nervous system, and dermatological/urinary system; OTC products in the areas of alimentary system, cold remedy, NSAID/respiratory system, dermatological, mouth and tooth, hepatic protectors, nutrients, tonics, topic analgesic, antihistamines, sore throat, and others; quasi drugs; health subsidiary foods; foods and drinks; and cosmetics. The company also exports its products. Dongwha Pharm.Co.,Ltd was founded in 1897 and is headquartered in Seoul, South Korea.
Visit company website
5 years, 5 months ago
Dongwha Pharm.Co.,Ltd is currently in a long term downtrend where the price is trading 4.6% below its 200 day moving average.
From a valuation standpoint, the stock is 82.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.5.
Dongwha Pharm.Co.,Ltd's total revenue sank by 17.6% to $69B since the same quarter in the previous year.
Its net income has dropped by 2.3% to $8B since the same quarter in the previous year.
Finally, its free cash flow fell by 84.2% to $837M since the same quarter in the previous year.
Based on the above factors, Dongwha Pharm.Co.,Ltd gets an overall score of 1/5.